BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27283118)

  • 1. Continuous venovenous renal replacement therapy in critically ill patients: A work load analysis.
    Houllé-Veyssière M; Courtin A; Zeroual N; Gaudard P; Colson PH
    Intensive Crit Care Nurs; 2016 Oct; 36():35-41. PubMed ID: 27283118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent venovenous haemodiafiltration in critically ill patients with acute renal failure.
    Van Malderen P; De Rijck L; Vermaut M; Van Leuven G; De Bolle G; Billiouw JM; Lornoy W; Becaus I
    EDTNA ERCA J; 1998; 24(4):19-20. PubMed ID: 10222909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C; Mao Z; Kang H; Hu J; Zhou F
    Crit Care; 2016 May; 20(1):144. PubMed ID: 27176622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
    Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
    Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
    Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
    Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill?
    Kleger GR; Fässler E
    Int J Artif Organs; 2010 Mar; 33(3):139-46. PubMed ID: 20383858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of a program designed to improve continuous renal replacement therapy stability].
    Page M; Rimmelé T; Prothet J; Christin F; Crozon J; Ber CE
    Ann Fr Anesth Reanim; 2014 Dec; 33(12):626-30. PubMed ID: 25458458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faster Blood Flow Rate Does Not Improve Circuit Life in Continuous Renal Replacement Therapy: A Randomized Controlled Trial.
    Fealy N; Aitken L; du Toit E; Lo S; Baldwin I
    Crit Care Med; 2017 Oct; 45(10):e1018-e1025. PubMed ID: 28658026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional citrate anticoagulation for continuous renal replacement therapy in severe burns-a retrospective analysis of a protocol-guided approach.
    Gille J; Sablotzki A; Malcharek M; Raff T; Mogk M; Parentin T
    Burns; 2014 Dec; 40(8):1593-601. PubMed ID: 24612996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.
    Bellomo R; Farmer M; Boyce N
    J Intensive Care Med; 1995; 10(4):187-92. PubMed ID: 10155183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Renal Replacement Therapy and Anticoagulation: What Are the Options?
    Dirkes S; Wonnacott R
    Crit Care Nurse; 2016 Apr; 36(2):34-41. PubMed ID: 27037337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal replacement therapy in the intensive care unit].
    Morath C; Miftari N; Dikow R; Hainer C; Zeier M; Schwenger V; Weigand MA
    Anaesthesist; 2006 Aug; 55(8):901-13; quiz 914. PubMed ID: 16897018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review: Patency of the circuit in continuous renal replacement therapy.
    Joannidis M; Oudemans-van Straaten HM
    Crit Care; 2007; 11(4):218. PubMed ID: 17634148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.